Sp38
WEIGHT LOSSS MEDICATIONS AND MASLD: WHICH MEDICATIONS WORK
Date
May 18, 2024
Presenter
Weill Cornell Medical College
Tracks
Related Products
PROSPECTIVE, MATCHED CASE-CONTROL STUDY OF ENDOSCOPIC SLEEVE GASTRECTOMY AND SEMAGLUTIDE IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
Background: Nonalcoholic steatohepatitis (NASH) is a major cause of liver-related morbidity, mortality, and the leading indication for liver transplant in the US. Fibrosis is the best predictor of clinical outcomes in NASH…
PANEL DISCUSSION
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic…
A RANDOMIZED, DOUBLE-BLIND, TWO-WAY CROSSOVER STUDY TO EVALUATE THE EFFICACY OF LIRAGLUTIDE TREATMENT IN PATIENTS UNDERGOING TRANSORAL OUTLET REDUCTION ENDOSCOPY
Background: Transoral outlet reduction endoscopy (TORe) has been shown to be effective in managing weight regain after Roux-en-Y gastric bypass (RYGB), as has the glucagon-like peptide-1 agonist, liraglutide. However, the effect of adjunctive liraglutide after TORe has yet to be assessed…
INTERDISCIPLINARY MODELS OF NUTRITION AND OBESITY CARE: INCORPORATING DIETITIANS AND COLLABORATING SPECIALISTS INTO GASTROENTEROLOGY TRAINING AND PRACTICE
This session, designed for the fellows, clinician educator and program director focuses on designing and delivering curricula for GI fellows on the topics of nutrition, including the obesity epidemic…
